Company Search:
Advanced Search
Sponsored Links
EirGenix Inc Company Snapshot
EirGenix Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares EirGenix Inc with three other pharmaceutical manufacturers in Asia: Eu Biologics Co Ltd of South Korea (2017 sales of 11.57 billion Korean Won [US$10.27 million] ), Mycenax Biotech Incorporated (318.64 million Taiwanese Dollars [US$10.33 million] of which 98% was Technical Service Income), and Alteogen Inc which is based in South Korea (12.10 billion Korean Won [US$10.75 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
EirGenix Inc
  Stock Performance Chart for EirGenix Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 36.09
(Figures in Taiwanese Dollars)
1 Week n/a   13 Weeks 2.8%  
4 Weeks 16.9%   52 Weeks 43.9%  
EirGenix Inc Key Data:
  Ticker: 6589 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 297,866,000
(Year Ending Jan 2018).
Employees: 170
  Currency: Taiwanese Dollars Market Cap: 4,476,423,150
  Fiscal Yr Ends: December Shares Outstanding: 124,035,000
  Share Type: GU Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.